• Keros Therapeutics (NASDAQ:KROS) Price Target Lowered to $44.00 at Scotiabank

    المصدر: Buzz FX / 14 ديسمبر 2024 17:06:11   America/New_York


    Keros Therapeutics (NASDAQ:KROS) Price Target Lowered to $44.00 at Scotiabank Written by MarketBeat December 14, 2024 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) had its price target decreased by equ
    Read more...
شارك على،